Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: Maximum entropy estimates of splice junction strengths
- 19 December 2003
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 23 (1), 67-76
- https://doi.org/10.1002/humu.10295
Abstract
Ataxia‐telangiectasia (A‐T) is an autosomal recessive neurological disorder caused by mutations in the ATM gene. Classical splicing mutations (type I) delete entire exons during pre‐mRNA splicing. In this report, we describe nine examples of nonclassical splicing mutations in 12 A‐T patients and compare cDNA changes to estimates of splice junction strengths based on maximum entropy modeling. These mutations fall into three categories: pseudoexon insertions (type II), single nucleotide changes within the exon (type III), and intronic changes that disrupt the conserved 3′ splice sequence and lead to partial exon deletion (type IV). Four patients with a previously reported type II (pseudoexon) mutation all shared a common founder haplotype. Three patients with apparent missense or silent mutations actually had type III aberrant splicing and partial deletion of an exon. Five patients had type IV mutations that could have been misinterpreted as classical splicing mutations. Instead, their mutations disrupt a splice site and use another AG splice site located nearby within the exon; they lead to partial deletions at the beginning of exons. These nonclassical splicing mutations create frameshifts that result in premature termination codons. Without screening cDNA or using accurate models of splice site strength, the consequences of these genomic mutations cannot be reliably predicted. This may lead to further misinterpretation of genotype–phenotype correlations and may subsequently impact upon gene‐based therapeutic approaches. Hum Mutat 23:67–76, 2004.Keywords
Funding Information
- A-T Medical Research Foundation
- NIH (NS35322, CA76513)
- DFG (Do-371/2-1)
This publication has 35 references indexed in Scilit:
- ATM mutations on distinct SNP and STR haplotypes in ataxia-telangiectasia patients of differing ethnicities reveal ancestral founder effectsHuman Mutation, 2002
- ATM heterozygosity and cancer riskNature Genetics, 2002
- Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancerNature Genetics, 2002
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- A new type of mutation causes a splicing defect in ATMNature Genetics, 2002
- Dominant Negative ATM Mutations in Breast Cancer FamiliesJNCI Journal of the National Cancer Institute, 2002
- The protein truncation test: A reviewHuman Mutation, 1999
- Splicing Defects in the Ataxia-Telangiectasia Gene, ATM: Underlying Mutations and ConsequencesAmerican Journal of Human Genetics, 1999
- Genomic Organization of the ATM GeneGenomics, 1996
- Ataxia-TelangiectasiaMedicine, 1991